A Flavonoid Inhibitor of 5-Lipoxygenase Inhibits Leukotriene Production Following Ischemia in Gerbil Brain
Masayuki Ban, MD, Takeharu L eukotrienes (LTs) are known to be chemical mediators of anaphylaxis and inflammation. 1 Among the various LTs, LTC 4 and LTD 4 are potent vasoconstrictors of human cerebral arteries in vitro 2 and increase vascular permeability.
3 - 4 Moskowitz et al 5 demonstrated enhanced synthesis of LTC 4 and LTD 4 in gerbil brain after ischemia and reperfusion; therefore, locally generated LTC4 and LTD 4 may be involved in the pathologic change in blood flow and the pathogenesis of edema.
In view of the proposed pathophysiologic roles of LTs, a number of compounds have been studied and developed as selective inhibitors of 5-lipoxygenase, the enzyme initiating LT biosynthesis from arachidonic acid. In previous studies of various flavonoids, we found that cirsiliol (3',4',5-trihydroxy-6,7-dimethoxyflavone) potently inhibited 5-lipoxygenase; furthermore, we studied its structure-activity relation 6 -7 and screened more potent derivatives. 8 A major disadvantage of cirsiliol and other flavonoids for in vivo studies is their hydrophobicity. Based on earlier work showing the advantages of a synthetic phosphate ester of baicalein for in vivo studies, 9 we synthesized a watersoluble derivative of cirsiliol (5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-disodium phosphate) and examined the effects of this inhibitor in a model of brain ischemia. To obtain its monophosphate, 500 mg of 5 -hexyloxy-3' ,4'-dihydroxy-6,7-dimethoxyflavone 8 was condensed with 19 g of polyphosphoric acid; the monophosphate was then neutralized with sodium hydroxide to give the 4'-disodium phosphate (360 mg, 60% yield). Identification of the compound was confirmed by ultraviolet absorption spectroscopy, elemental analysis, and nuclear magnetic resonance spectroscopy.
Materials and Methods

Mongolian gerbils (Meriones unguiculatus)
Arachidonate 5-lipoxygenase was purified from porcine leukocytes by immunoaffinity chromatography, 10 and enzyme activity was assayed with carbon-14-labeled arachidonic acid as the substrate in a standard reaction mixture fortified with calcium ions and ATP as described previously. 10 Frozen gerbil forebrain was homogenized in four volumes of cold 80% ethanol with a Polytron Model CH-6010 homogenizer (Kinematica, Luzern, Switzerland). After centrifugation at 9,500g for 20 minutes at -20° C, 2 ml of the supernatant was evaporated in vacuo. The dried residue was resuspended in 1 ml of a buffer (10 mM sodium phosphate buffer, pH 7.3, containing 0.1 M NaCl, 1 mM MgCl 2 , and 0.1% NaN 3 ) and then centrifuged at l,500g for 10 minutes. Recoveries of PGD 2 and LTC 4 in the extraction procedure were approximately 70% and 40%, respectively, using tritium-labeled compounds as internal standards. The 80% ethanol extract was further purified by the use of a Sep-Pak C, 8 column essentially by the method of Powell." Highperformance liquid chromatography (HPLC) using a Nova-Pak C )8 Radial Pak column (0.8x 10 cm) was performed to identify LTC 4 and LTD 4 (at 280 nm) and PGD 2 (at 192 nm). PGD 2 was eluted with acetonitrile:water:acetic acid 35:65:0.1 by vol and LTC 4 and LTD 4 were eluted with acetonitrile: methanol: water: acetic acid 300:100:400:0.8 by vol, adjusted to pH 5.7 with ammonium hydroxide, at a flow rate of 1.0 ml/min.
For PGD 2 radioimmunoassay, anti-PGD 2 , [5,6,8, 9,12,14,15- No. NIH78-23, revised 1978). Mongolian gerbils lack the anastomosis between the carotid and vertebrobasilar circulations, and temporary occlusion of both carotid arteries produces forebrain ischemia. 12 Both common carotid arteries were exposed under an operative microscope while the gerbils were briefly anesthetized with diethyl ether; tracheotomy was done to prevent respiratory difficulties. An aneurysm clip was applied to each common carotid artery simultaneously, maintained in place for 15 minutes, and then removed to allow reperfusion. After 15 minutes of reperfusion, the whole gerbil was frozen in liquid nitrogen and decapitated. Shamoccluded gerbils had their common carotid arteries exposed under ether anesthesia but not occluded. A polyethylene catheter was inserted into the left femoral vein for sampling of blood and intravenous injection of 200 ^tl of the flavonoid 5-lipoxygenase inhibitor or its vehicle (physiological saline). The flavonoid was dissolved in vehicle, and the pH was adjusted to 7.4 with IN sodium hydroxide.
Plasma from the blood sample was mixed with PGB 2 as an internal standard, and then the mixture was extracted with ethyl acetate: methanol 2:1 by vol. After centrifugation, the supernatant was evaporated to dryness in vacuo. The extract was analyzed by reverse-phase HPLC using acetonitrile: methanol: water 300:100:250 by vol, containing 111 mM phosphoric acid, at a flow rate of 1.0 ml/min. The average retention time was 9.0 minutes for PGB 2 , 5.8 minutes for the ester form, and 17.4 minutes for the free form of the flavonoid. For quantification of the flavonoid, its peak area (325 nm) and that of PGB 2 (278 nm) were calculated, and the flavonoid: PGB 2 ratio was plotted against varying amounts of flavonoid to obtain a standard curve.
Results
Our previous study of the structure-activity relations of flavonoids as 5-lipoxygenase inhibitors indicated an important role of the catechol structure in the B ring of flavone. 7 Since one of the catecholic hydroxyl groups was esterified with a phosphate in the water-soluble flavonoid used in this work (5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone4'-disodium phosphate), its inhibitory effect on 5-lipoxygenase purified from porcine leukocytes was tested, using the unesterified form as a control. The esterified form was less active than the free form by one order of magnitude (Figure 1 ). In view of the reported effect of baicalein 6-phosphate in experi- mental asthma, 13 we applied the water-soluble flavonoid to an in vivo study using Mongolian gerbils as a model of brain ischemia.
Production of PGD 2 and LTC 4 in ischemic gerbil brain was assessed by radioimmunoassay, the validity of which was examined in two types of experiments. There was a linear relation between the volume of brain extract and the amount of PG or LT measured by radioimmunoassay. On the other hand, when a given amount of brain extract was mixed with various amounts of PGD 2 or LTC 4 and the mixtures were subjected to radioimmunoassay, a nearly linear relation was observed between the amount of PG or LT added and the result of the radioimmunoassay.
When ethanol extract from the brain of a gerbil subjected to ischemia for 15 minutes and reperfusion for 15 minutes was purified using Sep-Pak C| 8 cartridges and analyzed by HPLC, increased production of PGD 2 ( Figure 2C ) and LTC 4 and LTD 4 ( Figure 2G ) was observed; such increases were not observed in sham-occluded gerbils ( Figure 2B for PGD 2 , Figure 2F for LTC 4 and LTD 4 ). Production of LTC 4 and LTD 4 was markedly reduced when the gerbils received the flavonoid 5-lipoxygenase inhibitor before carotid occlusion and reperfusion ( Figure  2H) ; administration of the flavonoid did not affect PGD 2 concentration ( Figure 2D) .
Reperfusion increased the production of LTC 4 and LTD 4 from a baseline concentration of <1 to a mean±SEM concentration of 12.8±3.9 pmol/g brain (n=6) and the PGD 2 concentration from <3 to a mean±SEM concentration of 174.7±20.1 pmol/g brain (n=6). Inhibition of enhanced LT synthesis depended on the dose of flavonoid, and maximum inhibition was observed at a flavonoid dose of 200 mg/kg body wt (Figure 3 ). PGD 2 
Effluent was analyzed by radioimmunoassay for PGD2 (B-D) and LTCJD 4 (F-H).
by administration of the flavonoid 5-30 minutes before bilateral carotid artery occlusion (Figure 4) .
The metabolic fate of the flavonoid 4'-phosphate (of >99% purity as the esterified form) was also studied, expecting removal of its phosphate in vivo after its intravenous administration to gerbils. Only approximately 7% of the flavonoid appearing in the blood stream after 15 minutes was in an unesterified form, which was more potent in inhibiting 5-lipoxygenase (Table 1) .
Discussion
Mongolian gerbils have been used by many investigators as an animal model for brain ischemia. 12 A number of articles have been published reporting increased production of various PGs (PGE2, PGD 2 , PGI 2 , and their metabolites) and thromboxane in the gerbil brain after transient ischemia followed by reperfusion. 14 -20 More recently an increase of the LT concentration was demonstrated in the ischemic gerbil brain after reperfusion 5 and in subarachnoid hemorrhage and concussive brain injury. 21 The pathologic roles of these PGs and LTs have been discussed; special attempts were made to correlate the development of brain edema with increased synthesis of PGs 131819 and LTs. 5 Since the development of brain edema was not prevented by treatment of the gerbils with indomethacin, 23.3±3.7
Data are mean±SEM /ig/ml in plasma after injection of 200 mg/kg body wt 5-lipoxygenase inhibitor; plasma was analyzed by reverse-phase high-performance liquid chromatography as described in "Materials and Methods." which inhibited cyclooxygenase and reduced PG production, 15 a possible role of LTs with a biologic activity to enhance vascular permeability was sought in the pathogenesis of brain edema. 3 Indeed, an article reported that direct application of LTs to brain parenchyma enhanced Evans blue extravasation in rats. 22 Thus, it was desirable to develop a drug to block the biosynthesis of LTs and their receptor interaction. 5 We have been developing various flavonoids as selective inhibitors of arachidonate 5-lipoxygenase. 6 -8 While chemically modifying these flavonoids, we developed a water-soluble flavonoid (5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-disodium phosphate) as a 5-lipoxygenase inhibitor. Intravenous injection of the water-soluble flavonoid before bilateral carotid artery occlusion markedly reduced LT production, which was enhanced after reperfusion of the ischemic brain. Maximum inhibition required a dose as high as 200 mg/kg body wt. The need for such a high dose may be attributed to slow deesterification of the less potent phosphate ester form to a more active free form. Blood analysis demonstrated that a small portion of the injected prodrug was actually converted to an active unesterified form in the circulating blood at the end of ischemia and reperfusion (Table 1) . To circumvent some of these problems, we are now developing a more potent 5-lipoxygenase inhibitor. Alternative methods of drug administration must also be investigated.
The 5-lipoxygenase inhibitor thus developed must be applied to study of the pathogenesis of brain edema following ischemia and reperfusion with special reference to a possible role of LTs. A previous report suggested the roles of two types of PGs in the two phases of pathogenesis of brain edema: PGFî n cytotoxic edema examined by specific gravity measurement and PGE2 in vasogenic edema followed by Evans blue staining. 18 Therefore, a precise time relation must be investigated between LT biosynthesis and edema formation, and the flavonoid 5-lipoxygenase inhibitor must be used in this line of study.
Several more problems remain to be investigated further. We still do not know whether LTs are produced by neuronal cells, glial cells, or infiltrating leukocytes. A precise knowledge of the regional 
